本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Adaptimmune Therapeutics plc

0.2500
+0.00763.14%
成交量:45.99万
成交额:11.45万
市值:6,626.29万
市盈率:-0.86
高:0.2548
开:0.2460
低:0.2400
收:0.2424
数据加载中...
2024/02/16

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/30

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/06

重要事件披露

Form 8-K - Current report
2023/12/01

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/03

重要事件披露

Form 8-K - Current report
2023/10/31

重要事件披露

Form 8-K - Current report
2023/08/31

重要事件披露

Form 8-K - Current report
2023/08/10

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/08/09

重要事件披露

Form 8-K - Current report
2023/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments